This BioPharma Could Be First To Market With Its Celiac Therapy

James Sapirstein, Chairman, President & CEO of First Wave BioPharma, Inc. FWBI was recently a guest on Benzinga’s All-Access. First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.…#jamessapirstein #benzingasallaccess #firstwavebiopharma
Source: Reuters: Health - Category: Consumer Health News Source Type: news